HomeCommentary

Commentary

As AG Momentum Continues, Mucosta AG to Hit Shelves 8 Years after Gx Entry
(Jun.14.2017)

By Takashi Ebisawa

As authorized generics (AGs) capture the lion’s share of their respective generic market in Japan, the Otsuka group is to roll out an AG version of its peptic ulcer med Mucosta (rebamipide) eight years after the drug’s generic entry, apparently looking to jump on the AG bandwagon amid lingering concerns over the quality of non-AG generics ...

(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 28.

News Calendar